Skip to main content

Taysha Gene Therapies, Inc.

TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001806310

In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Taysha Gene Therapies, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
−1 vs. Q2 2021
Shares held
19.4M
+1.11M (+6.1%) vs. Q2 2021
Total value
$361.9M
−$26.6M (−6.9%) vs. Q2 2021
New holders
4
21 more added
Sold out
5
11 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TSHA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 48 institutions
Q1 2021: 46 institutionsQ2 2021: 49 institutionsQ3 2021: 48 institutionsQ4 2021: 65 institutionsQ1 2022: 71 institutionsQ2 2022: 59 institutionsQ3 2022: 54 institutionsQ4 2022: 52 institutionsQ1 2023: 44 institutionsQ2 2023: 39 institutionsQ3 2023: 63 institutionsQ4 2023: 87 institutionsQ1 2024: 109 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 127 institutionsQ2 2025: 150 institutionsQ3 2025: 155 institutionsQ4 2025: 195 institutionsQ1 2026: 191 institutionsQ2 2026: 208 institutions
Value heldQ3 2021: $361.9M
Q1 2021: $358.5MQ2 2021: $388.6MQ3 2021: $361.9MQ4 2021: $215.6MQ1 2022: $110.9MQ2 2022: $54.7MQ3 2022: $27.0MQ4 2022: $43.8MQ1 2023: $13.3MQ2 2023: $9.05MQ3 2023: $410.6MQ4 2023: $230.3MQ1 2024: $402.2MQ2 2024: $354.3MQ3 2024: $315.5MQ4 2024: $289.8MQ1 2025: $232.0MQ2 2025: $595.4MQ3 2025: $865.6MQ4 2025: $1.48BQ1 2026: $1.18BQ2 2026: $2.03B
Institutions holding TSHA and their total value by quarter
QuarterHoldersValue
Q2 2026208$2.03B
Q1 2026191$1.18B
Q4 2025195$1.48B
Q3 2025155$865.6M
Q2 2025150$595.4M
Q1 2025127$232.0M
Q4 2024131$289.8M
Q3 2024119$315.5M
Q2 2024107$354.3M
Q1 2024109$402.2M
Q4 202387$230.3M
Q3 202363$410.6M
Q2 202339$9.05M
Q1 202344$13.3M
Q4 202252$43.8M
Q3 202254$27.0M
Q2 202259$54.7M
Q1 202271$110.9M
Q4 202165$215.6M
Q3 202148$361.9M
Q2 202149$388.6M
Q1 202146$358.5M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Taysha Gene Therapies, Inc.; share changes are against Q2 2021.

Institutions holding TSHA in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC5,758,674$107.2M0.01%+71,058+1.2%Added
BlackRock Inc.3,021,969$56.3M0.00%+55,198+1.9%Added
Franklin Resources Inc1,310,210$24.4M0.01%+4,364+0.3%Added
Nantahala Capital Management, LLC1,249,309$23.3M1.37%+817,237+189.1%Added
University of Texas/Texas Am Investment Managment Co1,147,040$21.4M12.20%−244,150−17.5%Reduced
Artal Group S.A.1,040,882$19.4M0.48%00.0%Unchanged
Vanguard Group Inc805,718$15.0M0.00%+177,074+28.2%Added
Sands Capital Ventures, LLC724,873$13.5M2.04%+724,873New
TimesSquare Capital Management, LLC650,600$12.1M0.11%−32,800−4.8%Reduced
Alphabet Inc.640,882$11.9M0.28%00.0%Unchanged
Tybourne Capital Management (HK) Ltd500,000$9.31M0.23%00.0%Unchanged
JPMorgan Chase & Co420,362$7.83M0.00%+206,716+96.8%Added
Geode Capital Management, LLC363,016$6.76M0.00%+99,574+37.8%Added
State Street Corp352,186$6.56M0.00%+33,567+10.5%Added
Perceptive Advisors LLC320,440$5.97M0.09%00.0%Unchanged
Northern Trust Corp211,928$3.95M0.00%+13,069+6.6%Added
Charles Schwab Investment Management Inc158,407$2.95M0.00%+71,377+82.0%Added
Morgan Stanley125,094$2.33M0.00%+88,984+246.4%Added
Nuveen Asset Management, LLC92,374$1.72M0.00%+11,952+14.9%Added
Davenport & Co LLC82,770$1.54M0.01%+69,020+502.0%Added
Bank of New York Mellon Corp73,745$1.37M0.00%+17,073+30.1%Added
Granite Point Capital Management, L.P.40,000$745.0K0.29%−10,000−20.0%Reduced
Gilder Gagnon Howe & Co LLC37,578$700.0K0.00%−62−0.2%Reduced
Swiss National Bank37,500$698.0K0.00%00.0%Unchanged
UBS Group AG33,383$622.0K0.00%+28,083+529.9%Added
Bank of America Corp32,677$608.0K0.00%+8,298+34.0%Added
State of Wisconsin Investment Board28,800$536.0K0.00%00.0%Unchanged
California State Teachers Retirement System25,954$483.0K0.00%−4,758−15.5%Reduced
Rhumbline Advisers20,131$375.0K0.00%+1,460+7.8%Added
New York State Common Retirement Fund14,327$267.0K0.00%−4,847−25.3%Reduced
Credit Suisse AG13,452$249.0K0.00%+63+0.5%Added
Deutsche Bank AG13,108$244.0K0.00%−414−3.1%Reduced
Manufacturers Life Insurance Company, The12,314$229.0K0.00%−651−5.0%Reduced
American International Group, Inc.12,184$227.0K0.00%−290−2.3%Reduced
Goldman Sachs Group Inc12,099$225.0K0.00%+12,099New
MetLife Investment Management9,509$177.1K0.00%00.0%Unchanged
SG Americas Securities, LLC9,168$171.0K0.00%+9,168New
Virtus ETF Advisers LLC8,268$154.0K0.07%−429−4.9%Reduced
Metropolitan Life Insurance Co7,280$135.6K0.00%00.0%Unchanged
Legal & General Group Plc7,107$132.0K0.00%+3,358+89.6%Added
Citigroup Inc3,321$62.0K0.00%+1,950+142.2%Added
Macquarie Group Ltd2,210$41.0K0.00%+2,210New
Royal Bank of Canada2,017$38.0K0.00%+485+31.7%Added
Ameritas Investment Partners, Inc.1,745$32.0K0.00%00.0%Unchanged
Captrust Financial Advisors1,021$19.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)790$15.0K0.00%−186−19.1%Reduced
Brewin Dolphin Ltd250$4.66K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.241$4.00K0.00%00.0%Unchanged
Sands Capital Management, LLC0$00.00%−724,873−100.0%Sold out
Octagon Capital Advisors LP0$00.00%−320,440−100.0%Sold out
Pura Vida Investments, LLC0$00.00%−33,822−100.0%Sold out
Millennium Management LLC0$00.00%−30,165−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−11,448−100.0%Sold out